Have a personal or library account? Click to login
Dosimetric evaluation of an ipsilateral intensity modulated radiotherapy beam arrangement for parotid malignancies Cover

Dosimetric evaluation of an ipsilateral intensity modulated radiotherapy beam arrangement for parotid malignancies

Open Access
|Oct 2013

References

  1. 1. Garden AS, el-Naggar AK, Morrison WH, Callender DL, Ang KK, Peters LJ. Postoperative radiotherapy for malignant tumors of the parotid gland. Int JRadiat Oncol Biol Phys 1997; 37: 79-85.10.1016/S0360-3016(96)00464-6
  2. 2. Bailey DW, Kumaraswamy L, Podgorsak MB. A fully electronic intensitymodulated radiation therapy quality assurance (IMRT QA) process implemented in a network comprised of independent treatment planning, record and verify, and delivery systems. Radiol Oncol 2010; 44: 124-30.10.2478/v10019-010-0017-9
  3. 3. Nutting CM, Rowbottom CG, Cosgrove VP, Henk JM, Dearnaley DP, Robinson MH et al. Optimisation of radiotherapy for carcinoma of the parotid gland: a comparison of conventional, three-dimensional conformal, and intensitymodulated techniques. Radiother Oncol 2001; 60: 163-72.10.1016/S0167-8140(01)00339-5
  4. 4. Chang SX, Cullip TJ, Rosenman JG, Halvorsen PH, Tepper JE. Dose optimization via index-dose gradient minimization. Med Phys 2002; 29: 1130-46.10.1118/1.1478560
  5. 5. Yaparpalvi R, Fontenla DP, Tyerech SK, Boselli LR, Beitler JJ. Parotid gland tumors: a comparison of postoperative radiotherapy techniques using three dimensional (3D) dose distributions and dose-volume histograms (DVHS). Int J Radiat Oncol Biol Phys 1998; 40: 43-9.10.1016/S0360-3016(97)00484-7
  6. 6. Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011; 12: 127-36.10.1016/S1470-2045(10)70290-4
  7. 7. Rowbottom CG, Nutting CM, Webb S. Beam-orientation optimization of intensity-modulated radiotherapy: clinical application to parotid gland tumours. Radiother Oncol 2001; 59: 169-77.10.1016/S0167-8140(00)00321-2
  8. 8. Bragg CM, Conway J, Robinson MH. The role of intensity-modulated radiotherapy in the treatment of parotid tumors. Int J Radiat Oncol Biol Phys 2002; 52: 729-38.10.1016/S0360-3016(01)02660-8
  9. 9. Chao KS, Deasy JO, Markman J, Haynie J, Perez CA, Purdy JA, et al. A prospective study of salivary function sparing in patients with head-andneck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 2001; 49: 907-16.10.1016/S0360-3016(00)01441-3
  10. 10. Blanco AI, Chao KS, El Naqa I, Franklin GE, Zakarian K, Vicic M, et al. Dosevolume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. Int J Radiat Oncol Biol Phys 2005; 62: 1055-69.10.1016/j.ijrobp.2004.12.076
  11. 11. Deasy JO, Moiseenko V, Marks L, Chao KS, Nam J, Eisbruch A. Radiotherapy dose-volume effects on salivary gland function. Int J Radiat Oncol Biol Phys 2010; 76: S58-63.10.1016/j.ijrobp.2009.06.090
DOI: https://doi.org/10.2478/raon-2013-0010 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 411 - 418
Published on: Oct 8, 2013
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2013 Eda Yirmibesoglu, David V. Fried, Mark Kostich, Julian Rosenman, William Shockley, Mark Weissler, Adam Zanation, Bhishamjit Chera, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.